A New Mechanism Of Immune Regulation That Limits The Efficacy Of Immunotherapy
Immunotherapy with checkpoint blockade has revolutionized cancer treatment in the last decade. With the initial FDA approval of CTLA-4 blockade with ipilimumab in 2011 followed…
Read more










